These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11783482)

  • 1. Effect of losartan and furosemide on the urinary excretion of oxypurinol and uric acid.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    Adv Exp Med Biol; 2000; 486():185-8. PubMed ID: 11783482
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of furosemide on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the angiotensin II receptor antagonist losartan on uric acid and oxypurine metabolism in healthy subjects.
    Hamada T; Hisatome I; Kinugasa Y; Matsubara K; Shimizu H; Tanaka H; Furuse M; Sonoyama K; Yamamoto Y; Ohtahara A; Igawa O; Shigemasa C; Yamamoto T
    Intern Med; 2002 Oct; 41(10):793-7. PubMed ID: 12412998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of losartan potassium, an angiotensin II receptor antagonist, on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    J Rheumatol; 2000 Sep; 27(9):2232-6. PubMed ID: 10990239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bovine milk ingestion on urinary excretion of oxypurinol and uric acid.
    Kurajoh M; Ka T; Okuda C; Yamamoto A; Tsutsumi Z; Koyama H; Moriwaki Y; Yamamoto T
    Int J Clin Pharmacol Ther; 2011 Jun; 49(6):366-70. PubMed ID: 21612743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glucagon on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hiroishi K; Yamakita J; Nakano T; Higashino K
    J Rheumatol; 1997 Apr; 24(4):708-13. PubMed ID: 9101506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
    Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
    Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    Metabolism; 2001 Oct; 50(10):1230-3. PubMed ID: 11586499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin II infusion on renal excretion of purine bases and oxypurinol.
    Moriwaki Y; Yamamoto T; Tsutsumi Z; Takahashi S; Hada T
    Metabolism; 2002 Jul; 51(7):893-5. PubMed ID: 12077737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of recurrent uric acid and calcium oxalate stones by administration of the xanthine oxidase inhibitors Milurit 100 and Milurit 300.
    Schneider HJ; Brundig P; Balogh A; Traeger A; Stein G; Fünfstück R
    Int Urol Nephrol; 1983; 15(2):121-9. PubMed ID: 6688800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man.
    Newby DE; Masumori S; Johnston NR; Boon NA; Webb DJ
    Cardiovasc Res; 1997 Nov; 36(2):268-75. PubMed ID: 9463638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine bases.
    Ka T; Inokuchi T; Tsutsumi Z; Takahashi S; Moriwaki Y; Yamamoto T
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):22-6. PubMed ID: 16425967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of switching from a combination of angiotensin II receptor blockers other than losartan and thiazides to a fixed dose of losartan/hydrochlorothiazide on uric acid metabolism in hypertensive patients.
    Ohshiro K; Sakima A; Nakada S; Kohagura K; Yamazato M; Tana T; Ohya Y
    Clin Exp Hypertens; 2011; 33(8):565-70. PubMed ID: 21958001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of DL-sodium lactate infusion on excretion of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):588-92. PubMed ID: 8314359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amino acids on the excretions of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Yamakita J; Higashino K
    Nephron; 1996; 73(1):41-7. PubMed ID: 8742955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    J Rheumatol; 2001 Oct; 28(10):2294-7. PubMed ID: 11669172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.
    Ohnishi K; Kohno M; Yukiiri K; Masugata H; Wada Y; Takagi Y; Ohmori K
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):417-22. PubMed ID: 11680666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological properties and its significance in clinical practice].
    Nishikibe M; Ikemoto F
    Nihon Rinsho; 1999 May; 57(5):1124-9. PubMed ID: 10361445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease.
    Ishimitsu T; Ohno E; Nakano N; Furukata S; Akashiba A; Minami J; Numabe A; Matsuoka H
    Clin Exp Hypertens; 2011; 33(6):366-72. PubMed ID: 21797795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.